drugset / Trial / NCT07057674
A Study of HS-20094 in Overweight or Obese Participants
RandomizedParallel-groupOpen-labelOther
Summary
This is a multicenter, randomized, open-label, parallel clinical study to evaluate the bioequivalence of the HS-20094 MDV pen and AI pen in overweight or obese subjects.
Timeline
- Start
- 2025-04-16
- Primary completion
- 2026-02-04
- Completion
- 2026-05-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olatorepatide | Protein / enzyme biologic | 15 mg | Subcutaneous |